MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma

Shi-hong Xu; Yong-liang Yang; Shu-mei Han; Zong-hui Wu
July 2014
World Journal of Surgical Oncology;2014, Vol. 12 Issue 1, p1
Academic Journal
Background The purpose of the present study was to examine the expression levels of microRNA-9 (miR- 9) in osteosarcoma tissues and normal bone tissues, and investigate the relationships between miR-9 expression, clinicopathological features and the prognosis of patients with osteosarcoma. Methods The expression levels of miR-9 in osteosarcoma tissues and corresponding non-cancerous tissues were detected using a real-time quantitative assay. Differences in patient survival were determined using the Kaplan-Meier method and a log-rank test. A Cox proportional hazards regression analysis was used for univariate and multivariate analyses of prognostic values. Results Compared to non-cancerous bone tissues, the expression levels of miR-9 in osteosarcoma tissues were significantly elevated (P < 0.001). We found that the expression level of miR-9 was significantly associated with tumor size (P = 0.011), clinical stage (P = 0.009) and distant metastasis (P < 0.001). The Kaplan-Meier curve showed that patients with low miR-9 expression survived significantly longer than patients with high miR-9 expression (P = 0.0017). Multivariate analysis suggested that miR-9 expression level (P = 0.002) is an independent prognostic factors for overall survival. Conclusions The findings of our study suggest that increased miR-9 expression has a strong correlation with the aggressive progression of osteosarcoma and its overexpression is a statistically significant risk factor affecting overall survival, suggesting that increased miR-9 expression could be a valuable marker of tumor progression and for prognosis of osteosarcoma.


Related Articles

  • Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma. Mirghasemi, Alireza; Taheriazam, Afshin; Karbasy, Seyyed Hasan; Torkaman, Ali; Shakeri, Mohammadreza; Yahaghi, Emad; Mokarizadeh, Aram // Cancer Cell International;2015, Vol. 15 Issue 1, p1 

    Background: MicroRNAs (miRNAs) play key roles in cancer development and progression. The purpose of the present study was to determine the expression levels of miR-133a and miR-539 in osteosarcoma patients and tofurther investigate the clinicopathological, and prognostic value of these miRNAs....

  • A new perspective on the IIIC staging in Chinese patients with primary breast cancer: Single-center experiences. Yu Z. H.; Yang Z. J.; Chen Q.; Xing F.; Zhang B.; Cao X. C.; Yu, Z H; Yang, Z J; Chen, Q; Xing, F; Zhang, B; Cao, X C // Indian Journal of Cancer;2015 Special issue 1, Vol. 52, pe6 

    Purpose: The purpose of this retrospective study was to investigate whether Stage IIIC (TanyN3M0) breast cancer can be classified further into subgroups with different prognosis.Materials and Methods: One hundred and thirty-two patients with Stage IIIC breast cancer at...

  • Tissue microRNA-126 expression level predicts outcome in human osteosarcoma. Wei Liu; Zhong-yuan Zhao; Lei Shi; Wen-dan Yuan // Diagnostic Pathology;7/1/2015, Vol. 10 Issue 1, p1 

    Background: MicroRNA-126 has been found to be consistently under-expressed in osteosarcoma tissues and cell lines compared with normal bone tissues and normal osteoblast cells, respectively. The purpose of the present study was to detect the expression levels of miR-126 in osteosarcoma patients...

  • Expression of microRNA-497 and its prognostic significance in human breast cancer. Shaohua Wang; Hanjun Li; Jingjie Wang; Dan Wang // Diagnostic Pathology;2013, Vol. 8 Issue 1, p1 

    Objective Dysregulation of microRNAs (miRNAs) plays critical roles in tumor progression. The aim of this study was to investigate the clinicopathologic and prognostic significance of miR-497 expression in human breast cancer (BC). Methods Taqman qRT-PCR assay was performed to detect the...

  • Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2. Limin Long; Guoqing Huang; Hongyi Zhu; Yonghong Guo; Youshuo Liu; Jirong Huo // Journal of Translational Medicine;2013, Vol. 11 Issue 1, p1 

    Background Colorectal cancer (CRC) is the most common digestive system malignancy. The molecular events involved in the development and progression of CRC remain unclear. Recently, more and more evidences have showed that deregulated miRNAs participate in colorectal carcinogenesis. Methods The...

  • High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma. Wen-yao Wang; Hong-fei Zhang; Lei Wang; Yan-peng Ma; Fei Gao; Shao-jun Zhang; Li-chao Wang // Diagnostic Pathology;2014, Vol. 9 Issue 1, p1 

    Background Whether microRNA-130b(miR-130b) can serve as a prognostic biomarker of hepatocellular carcinoma (HCC) has not been investigated. In the present study, we investigated the feasibility of miR-130b as a novel prognostic biomarker for HCC. Methods We retrospectively investigated 97...

  • Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer. Schee, Kristina; Boye, Kjetil; Abrahamsen, Torveig Weum; Fodstad, ┬Łystein; Flatmark, Kjersti // BMC Cancer;2012, Vol. 12 Issue 1, p505 

    Background: MicroRNAs (miRNAs) regulate gene expression by binding to mRNA, and can function as oncogenes or tumor suppressors depending on the target. In this study, using qRT-PCR, we examined the expression of six miRNAs (miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145) in tumors from...

  • A new prognostic scoring scale for patients with primary WHO grade III gliomas based on molecular predictors. Jiang, Haihui; Ren, Xiaohui; Zhang, Wei; Ma, Jun; Sui, Dali; Jiang, Zhongli; Cui, Xiangli; Lin, Song // Journal of Neuro-Oncology;Mar2013, Vol. 111 Issue 3, p367 

    This study was designed to select molecular markers associated with prognosis, and to propose a prognostic scoring scale for patients with primary WHO grade III gliomas based on these molecular predictors. A series of 83 grade III glioma patients surgically treated and pathologically confirmed...

  • Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy. Smoter, Marta; Bodnar, Lubomir; Grala, Bartlomiej; Stec, Rafal; Zieniuk, Krystyna; Kozlowski, Wojciech; Szczylik, Cezary // Journal of Experimental & Clinical Cancer Research (17569966);2013, Vol. 32 Issue 1, p1 

    Background: The aim of the study was to evaluate predictive and prognostic significance of microtubule-associated protein Tau in epithelial ovarian cancer (EOC) patients treated with paclitaxel and platinum-based chemotherapy. Methods: 74 patients with EOC (stage I-IV) who underwent...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics